A naturally occurring copper-binding tripeptide that declines sharply after age 20. GHK-Cu activates over 4,000 genes involved in tissue repair, collagen synthesis, anti-inflammatory response, and antioxidant defense. It attracts immune cells to injury sites, promotes angiogenesis, and remodels damaged tissue — making it the bridge between healing and anti-aging.
GHK-Cu's power comes from its ability to bind copper(II) ions and deliver them to tissue, activating a massive gene expression cascade. Research shows it upregulates genes for collagen, elastin, and glycosaminoglycan synthesis while simultaneously downregulating inflammatory and tissue-destruction genes. The net effect: accelerated repair, reduced scarring, and restored tissue architecture.
GHK-Cu is unique among healing peptides because it has both injectable and topical applications. SubQ injection provides systemic delivery for internal healing and anti-aging. Topical application (especially with microneedling) targets skin remodeling directly. Many protocols combine both routes for maximum effect.
GHK-Cu was first identified by Dr. Loren Pickart in the 1970s when he observed that liver tissue from young individuals had superior healing properties compared to older tissue. The active factor was identified as a copper-binding tripeptide whose circulating levels decline from ~200ng/mL at age 20 to ~80ng/mL by age 60.
Subsequent research revealed GHK-Cu's extraordinary breadth — it doesn't just heal wounds, it remodels tissue architecture, recruits stem cells, reduces scarring, and activates a gene expression profile that resembles youthful tissue. A 2014 Broad Institute study confirmed it modulates 31.2% of human genes, with a net effect of suppressing inflammation and activating repair.
Clinical applications span wound healing, post-surgical recovery, hair growth stimulation, and skin rejuvenation. The topical form is widely used in cosmetic dermatology with established efficacy for wrinkle reduction and skin texture improvement.
| Compound | Primary Target | Route | Depth | Best For |
|---|---|---|---|---|
| BPC-157 | Growth factors / GI | SubQ / Oral | Deep tissue | Tendons, gut, joints |
| TB-500 | Actin / cell migration | SubQ | Systemic | Bodywide recovery |
| GHK-Cu | Gene expression / collagen | SubQ / Topical | Skin + systemic | Anti-aging, wounds, skin |
| LL-37 | Antimicrobial | SubQ | Immune | Infections, biofilm |
| Epithalon | Telomerase | SubQ | Cellular | Longevity, telomeres |
GHK-Cu's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
GHK-Cu occupies a unique position in the peptide space: it's simultaneously a healing peptide and an anti-aging compound. The gene expression data is extraordinary — 4,000+ genes modulated toward a youthful repair profile. For skin, it's arguably the most effective peptide available (topical or injectable). For systemic healing, it complements BPC-157 and TB-500 with a collagen-focused mechanism they don't have. The limitation is copper accumulation on very long cycles — monitor serum copper and maintain zinc supplementation. Run 8–12 week cycles with breaks, get copper/zinc levels checked, and combine with Vitamin C for collagen synthesis support.
Our free Protocol Guide includes the complete GLOW Stack with GHK-Cu — collagen protocols, topical formulation guidance, blood work panels, and anti-aging stack recommendations.